The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.

The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.

Chromosomal translocations are primary events in the development of leukemias, representing at least one genetic feature of the putative cancer stem cell. Studies of genes influenced by chromosomal translocations have yielded a vast amount of information about how cancer is initiated and maintained....

Bibliografiset tiedot
Päätekijät:	Nam, C, Rabbitts, T
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2006

Samankaltaisia teoksia

The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.
Tekijä: McCormack, M, et al.
Julkaistu: (2003)

Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.
Tekijä: Utpal P Davé, et al.
Julkaistu: (2009-05-01)

Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
Tekijä: McCormack, M, et al.
Julkaistu: (2004)

The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal.
Tekijä: McCormack, M, et al.
Julkaistu: (2010)

High frequency of cryptic chromosomal rearrangements involving the LMO2 gene in T-cell acute lymphoblastic leukemia
Tekijä: Lili Wu, et al.
Julkaistu: (2015-06-01)

Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice.
Tekijä: Tse, E, et al.
Julkaistu: (2004)

T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity.
Tekijä: Drynan, L, et al.
Julkaistu: (2001)

An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions.
Tekijä: Nam, C, et al.
Julkaistu: (2008)

Chromosomal translocation master genes, mouse models and experimental therapeutics.
Tekijä: Rabbitts, T
Julkaistu: (2001)

Modeling chromosomal translocations using conditional alleles to recapitulate initiating events in human leukemias.
Tekijä: Lobato, M, et al.
Julkaistu: (2008)

Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model
Tekijä: Pais, H, et al.
Julkaistu: (2019)

Identification of a high incidence region for retroviral vector integration near exon 1 of the <it>LMO2 </it>locus
Tekijä: Sakashita Kazuo, et al.
Julkaistu: (2009-09-01)

Chromosomal translocation products engender new intracellular therapeutic technologies.
Tekijä: Rabbitts, T, et al.
Julkaistu: (2003)

Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.
Tekijä: Appert, A, et al.
Julkaistu: (2009)

The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
Tekijä: Yamada, Y, et al.
Julkaistu: (2000)

Mutation of C/EBPalpha predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen.
Tekijä: Hasemann, MS, et al.
Julkaistu: (2008)

The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism.
Tekijä: Collins, E, et al.
Julkaistu: (2002)

LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.
Tekijä: Stephen Smith, et al.
Julkaistu: (2014-01-01)

The transcription factor complex LMO2/TAL1 regulates branching and endothelial cell migration in sprouting angiogenesis
Tekijä: Yoshihiro Yamada, et al.
Julkaistu: (2022-05-01)

Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
Tekijä: McCormack, M, et al.
Julkaistu: (2013)

Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia.
Tekijä: Collins, E, et al.
Julkaistu: (2002)

Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Tekijä: Gering, M, et al.
Julkaistu: (2003)

ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms
Tekijä: Steven Goossens, et al.
Julkaistu: (2019-08-01)

LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia
Tekijä: Ruggero, K, et al.
Julkaistu: (2016)

LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia
Tekijä: Ruggero, K, et al.
Julkaistu: (2016)

Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma
Tekijä: Divya Bansal, et al.
Julkaistu: (2023-01-01)

Chromosomal translocation engineering to recapitulate primary events of human cancer.
Tekijä: Forster, A, et al.
Julkaistu: (2005)

The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.
Tekijä: Yamada, Y, et al.
Julkaistu: (2002)

Application of Chromosome Conformation Capture Method for Detection MYC/TRD Chromosomal Translocation in Leukemia Cell Line
Tekijä: Moloud Absalan, et al.
Julkaistu: (2020-07-01)

Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complex
Tekijä: Sewell, H, et al.
Julkaistu: (2014)

Nonreciprocal chromosomal translocations in renal cancer involve multiple DSBs and NHEJ associated with breakpoint inversion but not necessarily with transcription.
Tekijä: Ali, H, et al.
Julkaistu: (2013)

Nonreciprocal chromosomal translocations in renal cancer involve multiple DSBs and NHEJ associated with breakpoint inversion but not necessarily with transcription
Tekijä: Ali, H, et al.
Julkaistu: (2013)

Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia
Tekijä: Rahman, Sunniyat, et al.
Julkaistu: (2018)

Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements
Tekijä: Irene Homminga, et al.
Julkaistu: (2012-02-01)

Ku70 affects the frequency of chromosome translocation in human lymphocytes after radiation and T-cell acute lymphoblastic leukemia
Tekijä: Zhenbo Cheng, et al.
Julkaistu: (2022-08-01)

Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
Tekijä: El Omari, K, et al.
Julkaistu: (2011)

Preclinical modeling of cytosine arabinoside response in Mll-Enl translocator mouse leukemias.
Tekijä: Cano, F, et al.
Julkaistu: (2008)

Deletion, insertion and translocation of DNA sequences contribute to chromosome size polimorphism in Plasmodium berghei
Tekijä: Chris J. Janse, et al.
Julkaistu: (1992-01-01)

Detecting statistically significant common insertion sites in retroviral insertional mutagenesis screens.
Tekijä: Jeroen de Ridder, et al.
Julkaistu: (2006-12-01)

Adult T-cell leukemia/lymphoma: A retroviral malady
Tekijä: Anza Khader, et al.
Julkaistu: (2012-01-01)